Alnylam Canada ULC
100%
Employees say this is a great place to work
Company Overview
About The Company
Alnylam is leading the translation of RNA interference into a whole class of innovative medicines with the potential to transform the lives of people affected with rare genetic, cardio-metabolic, hepatic infectious and central nervous system and ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for treating a wide range of severe, debilitating diseases. Founded in 2002, Alnylam is delivering on a bold vision to turn scientific possibility into reality, with a robust RNAi therapeutics platform. Alnylam is headquartered in Cambridge, MA. COMPANY SIZE
15
Industry
Biotechnology & Pharmaceuticals
HQ Location
Mississauga, Ontario
Interested in a career at Alnylam Canada ULC, or just want to know more?
To discover what sets Alnylam Canada ULC apart and explore relevant career opportunities, take a look at their website.
Company Culture at Alnylam Canada ULC
The employee experience below at Alnylam Canada ULC, compared to a typical company.
Learn More100% of employees at Alnylam Canada ULC say it is a great place to work compared to 60% of employees at a typical company.
Source: Great Place to Work® 2021 Global Employee Engagement Study.
Life at Alnylam Canada ULC
CONNECT